Advertisement

Health


Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Melbourne-based probiotics company Biome Australia (ASX: BIO) has s...

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

Queensland-based biotech startup Gutgutgoose has been accepted into...

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

Melbourne-based respiratory imaging company 4DMedical (ASX: 4DX) ha...

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo Healthcare & Wellness REIT (ASX: HCW) has secured a ne...

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

Digital health accelerator ANDHealth has awarded up to $9 million i...

Advertisement
Advertisement
Advertisement
New US trial finds AstraZeneca vaccine 79 per cent effective

New US trial finds AstraZeneca vaccine 79 per cent effective

A Phase III trial of the AstraZeneca vaccine in the US has demons...

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Buy-now pay-later (BNPL) operator Openpay (ASX: OPY) has announce...

IDT looks to manufacture COVID-19 vaccines on-shore

IDT looks to manufacture COVID-19 vaccines on-shore

Victorian pharmaceuticals manufacturer IDT Australia (ASX: IDT) h...

Centuria to build Melbourne hospital for doctor-led Medicare JV

Centuria to build Melbourne hospital for doctor-led Medicare JV

A subsidiary of Centuria Capital Group (ASX: CNI) has entered a p...

People Infrastructure acquires SwingShift Nurses

People Infrastructure acquires SwingShift Nurses

Workforce management company People Infrastructure (ASX: PPE) con...

Elixinol to bag German CBD brand for $13.9m

Elixinol to bag German CBD brand for $13.9m

Australian cannabis company Elixinol's (ASX: EXL) plans to pu...

Creso Pharma expanding into psychedelics with planned acquisition

Creso Pharma expanding into psychedelics with planned acquisition

Creso Pharma (ASX: CPH) is looking to tap into the emerging psych...

Mesoblast receives $138m injection from US investors

Mesoblast receives $138m injection from US investors

Australian biotechnology company Mesoblast (ASX: MSB) will receiv...

Investors like what they see under Healthia's skin, boosting its value to $185m

Investors like what they see under Healthia's skin, boosting its value to $185m

Allied health company Healthia Limited (ASX: HLA) has almost doub...

Needle-phobes rejoice: NeedleCalm launches in Australia

Needle-phobes rejoice: NeedleCalm launches in Australia

An innovative piece of medical technology aimed at reducing physi...

Medibank profit rises, CEO Craig Drummond to depart

Medibank profit rises, CEO Craig Drummond to depart

Private health insurance provider Medibank (ASX: MPL) has capital...

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Australian pharmaceutical company Starpharma's (ASX: SPL) ant...

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Mitigation measures against COVID-19 led to a drastic reduction i...

Profits double for IVF specialist Virtus Health

Profits double for IVF specialist Virtus Health

As the leading assisted reproductive services (ARS) company ...

Noxopharm study results herald "new era" for prostate cancer treatment

Noxopharm study results herald "new era" for prostate cancer treatment

A trial of Noxopharm's (ASX: NOX) prostate cancer treatment h...

Advertisement

Partner Content

Introduction: the natural desire to time marketsWhen investors cons...
IntroductionFor decades, term deposits have been a cornerstone of c...
Introduction: A Simple Line With Complex SignalsIn financial market...
Equi Consultancy Partners joined regional leaders at the WEConnect ...
If you run a business website, it’s easy to focus on what custome...
For many Australians, the journey with money begins in a very pract...
Introduction: How Investment Priorities Quietly Change Over TimeInv...
Advertisement